Arrowhead Pharmaceuticals Aktie
53,68
EUR
+0,14
EUR
+0,26
%
63,68
USD
-0,19
USD
-0,30
%
Werbung
Arrowhead Pharmaceuticals Aktie Analyse
| 07.09.18 | Arrowhead Pharmaceuticals Buy | B. Riley FBR | |
| 06.09.18 | Arrowhead Pharmaceuticals Buy | Chardan Capital Markets | |
| 08.08.18 | Arrowhead Pharmaceuticals Overweight | Cantor Fitzgerald | |
| 02.07.18 | Arrowhead Pharmaceuticals Buy | Chardan Capital Markets | |
| 09.05.18 | Arrowhead Pharmaceuticals Overweight | Cantor Fitzgerald | |
| 10.11.16 | Arrowhead Pharmaceuticals Buy | Chardan Capital Markets | |
| 19.05.16 | Arrowhead Pharmaceuticals Buy | Chardan Capital Markets |
Werbung
Werbung